Home / Nervous system / Oxcarbazepine
ATC N03AF02 · Antiepileptics
Oxcarbazepine shortage
As of 31 Oct 2026, Oxcarbazepine has a reported shortage in 3 of the 5 countries we track (Germany, Italy, Belgium), covering 4 products.
Countries3/5
Products4packs or presentations
Short since9 May 202518 months ago
Earliest return10 Nov 2026company estimate
No return date2products
Main reasonManufacturing problem
Timeline
GermanyItalyBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Oxcarbazepin - 1 A Pharma 60 mg/ml Suspension zum Einnehmen | 1 A Pharma GmbH | 9 May 2025 | 30 Nov 2026 | Other Sonstige |
| IT | TOLEP | NOVARTIS FARMA S.P.A. | 23 Jul 2025 | not given | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | TOLEP | NOVARTIS FARMA S.P.A. | 23 Jul 2025 | not given | Manufacturing problem Problemi produttivi: forniture discontinue |
| BE | Trileptal 300 mg film-coat. tabl. 50 | Novartis Pharma | 22 Oct 2026 | 10 Nov 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.